Qiagen Added to the BCW Index; BD Dropped on Clontech Sale

This week marks the first roster change in BioCommerce Week's 10-month existence. Qiagen, a multi-platform molecular biology tools provider, competes with many of the players already covered by BioCommerce Week and has partnerships with others. The company has been very active in the molecular biology tools space and has made several moves this year to expand its product range and geographic reach (see table below). As such, the Dutch firm has been added to the Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.